William Kucheman - Hill Rom Independent Director

Director

Mr. William H. Kucheman is an Independent Director of the Company. Before being named interim CEO in October 2011, he was Executive Vice President and President of the Cardiology, Rhythm and Vascular Group of Boston Scientific. He joined the company in 1995 as a result of Boston Scientifics acquisition of SCIMED Life Systems, Inc., becoming Senior Vice President of Marketing. In this role, Mr. Kucheman was responsible for global marketing. He has served on several industry boards, including the board of directors of the Global Health Exchange and on the boards of several nonpublic companies. since 2013.
Age 70
Tenure 11 years
Phone812 934-8189
Webwww.hillrom.com
Kucheman has served as a director of HillRom since 2013. He previously served as interim Chief Executive Officer for Boston Scientific Corporation Before being named interim CEO in October 2011, he was Executive Vice President and President of the Cardiology, Rhythm and Vascular Group of Boston Scientific. He joined the company in 1995 as a result of Boston Scientific’s acquisition of SCIMED Life Systems, Inc., becoming Senior Vice President of Marketing. In this role, Mr. Kucheman was responsible for global marketing. He has served on several industry boards, including the board of directors of the Global Health Exchange and on the boards of several nonpublic companies.

Hill Rom Management Efficiency

The company has Return on Asset of 6.13 % which means that on every $100 spent on assets, it made $6.13 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 13.78 %, implying that it generated $13.78 on every 100 dollars invested. Hill Rom's management efficiency ratios could be used to measure how well Hill Rom manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 2.16 B in debt with debt to equity (D/E) ratio of 1.15, which is OK given its current industry classification. Hill Rom Holdings has a current ratio of 1.35, which is typical for the industry and considered as normal. Debt can assist Hill Rom until it has trouble settling it off, either with new capital or with free cash flow. So, Hill Rom's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Hill Rom Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Hill to invest in growth at high rates of return. When we think about Hill Rom's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Michael LambertWestern Digital
69
Perry BlattVillage Super Market
48
Sanjay MehrotraWestern Digital
55
Stephanie StreeterWestern Digital
59
Alberto GonzalezGrupo Televisa SAB
89
Len LauerWestern Digital
59
Jon FeltheimerGrupo Televisa SAB
68
Stephen RooneyVillage Super Market
55
Steven CrystalVillage Super Market
61
Clayton RohrbachHanover Foods
88
Francisco RobeloGrupo Televisa SAB
90
Hong DuWeibo Corp
45
David ZaslavGrupo Televisa SAB
60
Kimberly AlexyWestern Digital
47
David JudgeVillage Super Market
55
Arthur SchaierHanover Foods
66
Julio HurtadoGrupo Televisa SAB
82
James SturgillHanover Foods
67
Jose FernandezGrupo Televisa SAB
61
Yong ZhangWeibo Corp
46
Paula PriceWestern Digital
55
Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. Hill-Rom Holdings, Inc. was founded in 1915 and is headquartered in Chicago, Illinois. Hill-Rom Holdings operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 10000 people. Hill Rom Holdings (HRC) is traded on New York Stock Exchange in USA and employs 10,000 people.

Management Performance

Hill Rom Holdings Leadership Team

Elected by the shareholders, the Hill Rom's board of directors comprises two types of representatives: Hill Rom inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hill. The board's role is to monitor Hill Rom's management team and ensure that shareholders' interests are well served. Hill Rom's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hill Rom's outside directors are responsible for providing unbiased perspectives on the board's policies.
Amy Dodrill, Senior Vice President and President Surgical Solutions
Michael Macek, VP and Treasurer
Stacy Seng, Independent Director
Enxing Seng, Director
Nancy Schlichting, Independent Director
Ilana Shulman, Chief Compliance Officer
William Dempsey, Non-Executive Independent Chairman of the Board
Felicia Norwood, Independent Director
Taylor Smith, Senior Vice President and Presidentident - Surgical and Respiratory Care
Richard Wagner, Chief Accounting Officer, Vice President, Controller
Anjana Harve, Chief Information Officer
Timothy Lawrence, Senior Vice President - Operations
Carlos Alonso, President Senior Vice President
Kenneth Meyers, Chief Human Resource Officer, Senior Vice President
Dirk Ehlers, Senior Vice President and Presidentident - Surgical Solutions
Francisco Vega, Senior Vice President - President Surgical Solutions
Eduardo Menasce, Independent Director
Jason Richardson, Vice President Corporate Controller
Carlyn Solomon, COO
Deborah Rasin, Senior Vice President Chief Legal Officer, Secretary
Carlos Marum, Senior Vice President and Presidentident - Hill-Rom International
Michiel Zwaan, Chief Human Resource Officer, Senior Vice President
John Greisch, CEO and President Director and Member of Mergers and Acquisitions Committee
Mary Ladone, Senior Vice President - Corporate Development, Strategy and Investor Relations
John Groetelaars, President, Chief Executive Officer, Director
Gregory Moore, Independent Director
Rolf Classon, Independent Chairman of the Board
Andreas Frank, Senior Vice President, President - Front Line Care Business
Mary Garrett, Independent Director
Ronald Malone, Lead Independent Director
Michael Murphy, Senior Vice President - Quality Assurance and Regulatory Affairs
James Giertz, Independent Director
Alton Shader, Sr. VP and President of Welch Allyn and President of Front Line Care
Steven Strobel, CFO and Sr. VP
Stanley Burhans, Vice President Corporate Controller
William Kucheman, Independent Director
Charles Golden, Independent Director
Paul Johnson, Senior Vice President and Presidentident of Patient Support Systems
Barbara Bodem, Chief Financial Officer, Senior Vice President
Gary Ellis, Independent Director
Brian Lawrence, Senior Vice President - Innovation and Connectivity and Chief Technology Officer
Susan Lichtenstein, Chief Legal Officer, Sr. VP of Corporate Affairs and Secretary
Kevin McCulloch, President Senior Vice President
Richard Marritt, Senior Vice President Chief Marketing Officer
SueJean Lin, Senior Vice President CIO
Richard Keller, Chief Accounting Officer, VP and Controller

Hill Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Hill Rom a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Hill Rom in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Hill Rom's short interest history, or implied volatility extrapolated from Hill Rom options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Consideration for investing in Hill Stock

If you are still planning to invest in Hill Rom Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hill Rom's history and understand the potential risks before investing.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Stocks Directory
Find actively traded stocks across global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
AI Investment Finder
Use AI to screen and filter profitable investment opportunities